Nabumetone
- Product NDC
- 45865-351
- 11-digit product format
- 458650351
- Labeler code
- 45865
- Product ID
- 45865-351_9701eac6-1397-8c82-e053-2a95a90a10f0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Nabumetone
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Medsource Pharmaceuticals
- Application
- ANDA078671
- Marketing category
- ANDA
- Marketing start
- 2008-03-01
- Marketing end
- 0000-00-00
- Substance
- NABUMETONE
- Active strength
- 750 mg/1
- Pharmacologic classes
- Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 45865-351-51 | Nabumetone | 120 in 1 BOTTLE | TABLET, FILM COATED | 120 | | 3 |
| 45865-351-60 | Nabumetone | 60 in 1 BOTTLE | TABLET, FILM COATED | 60 | | 3 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| NABUMETONE | ACTIVE INGREDIENT | LW0TIW155Z | NABUMETONE TABLET, FILM COATED [MEDSOURCE PHARMACEUTICALS] | 2 | |
| NABUMETONE | ACTIVE MOIETY | LW0TIW155Z | NABUMETONE TABLET, FILM COATED [MEDSOURCE PHARMACEUTICALS] | 2 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | NABUMETONE TABLET, FILM COATED [MEDSOURCE PHARMACEUTICALS] | 2 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | NABUMETONE TABLET, FILM COATED [MEDSOURCE PHARMACEUTICALS] | 2 | |
| FERRIC OXIDE YELLOW | INACTIVE INGREDIENT | EX438O2MRT | NABUMETONE TABLET, FILM COATED [MEDSOURCE PHARMACEUTICALS] | 2 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | NABUMETONE TABLET, FILM COATED [MEDSOURCE PHARMACEUTICALS] | 2 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | NABUMETONE TABLET, FILM COATED [MEDSOURCE PHARMACEUTICALS] | 2 | |
| POLYETHYLENE GLYCOL 200 | INACTIVE INGREDIENT | R95B8J264J | NABUMETONE TABLET, FILM COATED [MEDSOURCE PHARMACEUTICALS] | 2 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | NABUMETONE TABLET, FILM COATED [MEDSOURCE PHARMACEUTICALS] | 2 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | NABUMETONE TABLET, FILM COATED [MEDSOURCE PHARMACEUTICALS] | 2 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | NABUMETONE TABLET, FILM COATED [MEDSOURCE PHARMACEUTICALS] | 2 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | NABUMETONE TABLET, FILM COATED [MEDSOURCE PHARMACEUTICALS] | 2 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 45865-351 | NABUMETONE TABLET, FILM COATED [MEDSOURCE PHARMACEUTICALS] | 3 | Legacy NDC, 2 package rows | 20191111_1c6ea763-40f0-0cc9-e054-00144ff8d46c.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 45865-351-51 | 45865035151 | 120 TABLET, FILM COATED in 1 BOTTLE (45865-351-51) | 2015-08-03 | 0000-00-00 | No | No | Current |
| 45865-351-60 | 45865035160 | 60 TABLET, FILM COATED in 1 BOTTLE (45865-351-60) | 2015-08-03 | 0000-00-00 | No | No | Current |